Inhibitex to Host Conference Call to Report First Quarter 2009 Financial Results on May 12, 2009
May 01 2009 - 3:00PM
Business Wire
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host
a conference call on Tuesday, May 12, 2009 at 9:00 a.m. EDT to
review the Company�s first quarter ended March 31, 2009 financial
results and provide an update on recent corporate developments. The
Company will issue a press release regarding its financial results
on the same day, prior to the conference call.
Webcast Information
To access the conference call, please dial 877-407-8033
(domestic) or 201-689-8033 (international). A replay of the call
will be available from 11:00 a.m. EDT on May 12 until June 12, 2009
at midnight. To access the replay, please dial 877-660-6853
(domestic) or 201-612-7415 (international) and reference the
account # 286 and the conference id # 322241. A live audio webcast
of the call and the archived webcast will be available in the News
and Events section of the Inhibitex website at
http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company focused on developing products to treat
serious infectious diseases. The Company�s pipeline includes
FV-100, its clinical-stage oral nucleoside analogue in development
for the treatment of herpes zoster (shingles), as well as a series
of HCV nucleoside polymerase inhibitors and HIV integrase
inhibitors. Inhibitex has also licensed the use of its proprietary
MSCRAMM� protein technology to Wyeth for the development of
staphylococcal vaccines.
For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024